Phase II study of gemcitabine and docetaxel in patients with inoperable stage IIIB or IIIB or IV non-small cell lung cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Jul 2008 Biomarkers information updated
- 22 Aug 2005 New trial record.